Erratum to 'Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer - A study based on the EORTC trial 22881-10882 "boost versus no boost" ' (DOI:10.1016/j.ejca.2008.07.032);Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer - A study based on the EORTC trial 22881-10882 'boost versus no boost'

European Journal of Cancer

Volumn 44, Issue 17, 2008, Pages 2587-2599

  Collette, Sandra ^a   Collette, Laurence ^a   Budiharto, Tom ^a   Horiot, Jean Claude ^b   Poortmans, Philip M ^c   Struikmans, Henk ^d   Van den Bogaert, Walter ^e   Fourquet, Alain ^f   Jager, Jos J ^g   Hoogenraad, Willem ^h   Mueller, Rolf Peter ⁱ   Kurtz, John ^j   Morgan, David A L ^k   Dubois, Jean Bernard ^l   Salamon, Emile ^m   Mirimanoff, Rene ⁿ   Bolla, Michel ^o   Van der Hulst, Marleen ^c   Wárlám Rodenhuis, Carla C ^p   Bartelink, Harry ^q  

^a EORTC DATA CENTER   (Belgium)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

^c DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f INSTITUT CURIE   (France)

^g MAASTRO CLINIC   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Universitaetskliniken Köln ^*  (Germany)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^k NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^l CENTRE VAL D AURELLE   (France)

^m Clinique & Maternite Sainte Elisabeth Namer   (Belgium)

ⁿ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^o GRENOBLE UNIVERSITY HOSPITAL   (France)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q NETHERLANDS CANCER INSTITUTE   (Netherlands)

more..

Author keywords

Boost irradiation; Breast conserving treatment; Early breast cancer; Fibrosis; Nomograms

Indexed keywords

COBALT 60; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST FIBROSIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EARLY CANCER; FEMALE; FOLLOW UP; HEMATOMA; HIGH RISK POPULATION; HUMAN; LYMPHOCELE; MAJOR CLINICAL STUDY; MASTITIS; NOMOGRAM; PHOTON; POSTMENOPAUSE; POSTOPERATIVE EDEMA; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEROMA;

EID: 55549099566     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.013     Document Type: Erratum

References (26)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med 347 (2002) 1233-1241
2. Veronesi U., Casinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New Engl J Med 347 (2002) 1227-1232
3. Van Dongen J.A., Voogd A.C., and Fentiman I.S. Et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
4. Blichert-Toft M., Rose C., Andersen J.A., et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis - Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 11 (1992) 19-25
5. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. Danish Breast Cancer Cooperative Group. Breast Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol 19 6 (2001) 1688-1697
6. Arriagada R., Lê M.G., Rochard F., and Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol 14 (1996) 1558-1564
7. Early Breast CancerTrialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. The Lancet 366 (2005) 2087-2106
8. Curran D., Van Dongen J.P., Aaronson N.K., et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: Results of EORTC Trial 10801. Eur J Cancer 34 (1998) 307-314
9. Kiebert G.M., de Haes, and Van de Velde C.J. The impact of breast-conserving treatment and mastectomy on the quality of life of early breast cancer patients: a review. J Clin Oncol 9 (1991) 1059-1070
10. Schover L.R. The impact of breast cancer on sexuality, body image, and intimate relationships. CA Cancer J Clin 41 (1991) 112-120
11. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized Boost versus no Boost EORTC 22881-10882 Trial. J Clin Oncol 25 (2007) 3259-3265
12. Vrieling C., Collette L., Fourquet A., et al. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "Boost versus No Boost" trial. Int J Radiat Oncol Biol Phys 45 (1999) 677-685
13. International Commission on Radiation Units and Measurements. Dose specification for reporting external beam therapy with photons and electrons. Report 50. ICRU Publication, Bethesda, Maryland, USA, ICRU 1992.
14. Sauerbrei W., and Schumacher M. A bootstrap resampling procedure for model building: Application to the Cox regression model. Stat Med 11 (1992) 2093-2109
15. Schumacher M., Hollander N., and Sauerbrei W. Resampling and crossvalidation techniques: a tool to reduce bias caused by model building. Stat Med 16 (1997) 813-2827
16. Harrell F.E., Lee K.L., and Mark D.B. Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
17. Kattan M.W., Eastham J.A., Stapleton A.M.F., Wheeler T.M., and Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst Monogr 90 (1998) 766-771
18. Antonini N., Jones H., Horiot J., et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 82-3 (2007) 265-271
19. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8 (1982) 1981-1997
20. Borger J.H., Kemperman H., Smitt H.S., et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30 (1994) 1073-1081
21. Toledano A.H., Bollet M.A., Fourquet A., et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views. Int J Radiat Oncol Biol Phys 68 1 (2007) 66-72
22. Wazer D.E., Morr J., Erban J.K., et al. The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer 80 (1997) 732-740
23. Azria D., Gourgou S., Sozzi W.J., et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Brit J Cancer 91 (2004) 1251-1260
24. Taylor M.E., Perez C.A., Halverson K.J., et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31 (1995) 753-764
25. Fowble B., Fein D.A., Hanlon A.L., et al. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptorpositive early-stage breast cancer. Int J Radiat Oncol Biol Phys 35 (1996) 669-677
26. Donovan E., Bleakley N., Denholm E., et al. Randomized trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82 3 (2007) 254-264